IndeeLift, in partnership with Myositis Support and Understanding (MSU) is announcing a new program that combines the opportunity to...
The primary focus of Myositis Support and Understanding is muscle diseases which are referred to as “Idiopathic Inflammatory Myopathies” or “Acquired Myopathies,” meaning muscle diseases which are typically not inherited and are caused by the immune system attacking muscles, connective tissue, blood vessels, and/or the skin.
Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of DermatomyositisMyositis Support, , Dermatomyositis, Featured, Research
Corbus releases topline results for the phase 3 study of lenabasum in dermatomyositis. While it didn't meet the primary...
Orphazyme announces topline results of Phase 2/3 trial of arimoclomol for Inclusion Body Myositis (IBM)Myositis Support, , Featured, Inclusion Body Myositis (IBM), News
Learn more about the announcement from Orphazyme, communicating the topline results from the Phase 2/3 trial of arimoclomol for...
Orphazyme's Arimoclomol receives US Fast Track designation in sporadic Inclusion Body Myositis, an incurable rare progressively debilitating muscle-wasting disease...
Choose your language
- NEW IndeeLift 30” HFL-400-FTS
- Explore Myositis
- Financial Assistance Program
- Myositis Clinical Trials
- Myositis Empower Walk
- Myositis Webinars
- Scholarships to attend TMA conference
- The Grieving Project
- Upcoming Events